James Hardie Industries (JHX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Feb, 2026Executive summary
Achieved Q1 FY25 guidance with adjusted net income of $178 million and record adjusted EBITDA of $286 million, reflecting a 2% year-over-year increase in both metrics.
Net sales rose 4% to just under $1 billion, driven by higher average net sales prices across all regions.
Outperformed the market despite challenging conditions, maintaining operational focus and delivering value to customers.
Continued investment in capacity expansion, innovation, and strategic exits from non-core markets to support long-term growth.
Recognition for leadership and sustainability achievements, including industry awards and a forthcoming sustainability report.
Financial highlights
Net sales reached $991.9 million, up 4% year-over-year; adjusted EBITDA was $285.8 million, up 2%.
Adjusted net income totaled $178 million; adjusted diluted EPS was $0.41, up 4% from the prior year.
North America net sales up 5% to $729.3 million, EBIT margin at 31.2%, EBITDA margin at 36.1%.
$75 million in share repurchases executed in Q1, with authorization increased to $300 million.
Leverage ratio improved to 0.66x, marking 15 consecutive quarters at or below 1x.
Outlook and guidance
Fiscal 2025 guidance reaffirmed: North American volume expected at 2.95–3.15 billion square feet (flat ±3% vs. FY24).
North American EBIT margin expected between 29%–31% for the full year; adjusted net income guidance remains $630 million–$700 million; CapEx planned at $500–$550 million.
Q2 guidance: North American volumes 705–735 million standard feet, EBIT margin 27.5%–29.5%, adjusted net income $135–$155 million.
FY25 North America volume expected to be down low- to mid-single digits, with market outperformance of +4%.
Latest events from James Hardie Industries
- Q3 FY26 sales up 30% with higher EBITDA and synergy gains, but net income declined.JHX
Q3 202611 Feb 2026 - Q2 FY26 sales jumped 34% on AZEK deal; margins fell, but FY26 outlook and synergies improved.JHX
Q2 20263 Feb 2026 - H1 EBITDA topped $500m, FY25 guidance and buybacks raised despite lower sales.JHX
Q2 202514 Jan 2026 - FY25 met guidance; AZEK deal to drive $500M synergies; FY26 targets sales, EBITDA, and cash flow growth.JHX
H2 202514 Jan 2026 - Q3 FY25 delivered resilient margins, reaffirmed growth plans, and launched a new buyback program.JHX
Q3 20258 Jan 2026 - $8.75B merger targets $350M in synergies and forms a top building products growth platform.JHX
Business Combination27 Dec 2025 - Q1 FY26 sales fell 9%, AZEK acquisition closed, and early synergies are being realized.JHX
Q1 202623 Nov 2025 - Director re-elections and remuneration proposals faced rejection, while equity plans passed.JHX
AGM 202530 Oct 2025 - Merger with AZEK accelerates growth and market expansion through synergy and innovation.JHX
Jefferies Mining and Industrials Conference 202520 Oct 2025